Find Academic Supervisors

Shan RajendraView profile

Professor

• Gastroenterology
• Hepatology
• Oesophageal cancer
• +3 more

Professor Shan Rajendra is a distinguished researcher in the Faculty of Medicine at the University of New South Wales, specializing in gastroenterology with a particular focus on the relationship between human papillomavirus (HPV) and esophageal pathologies. His work is conducted through NSW Health in Liverpool, NSW, where he leads research investigating the infectious causes of gastrointestinal cancer with special emphasis on Barrett's oesophagus. Professor Rajendra's research interests center on oesophageal cancer , human papillomavirus , Barrett's oesophagus , and the Barrett's metaplasia-dysplasia-adenocarcinoma sequence . His laboratory employs histopathology and molecular biology techniques to investigate the mechanisms by which high-risk HPV contributes to esophageal carcinogenesis. A significant contribution to the field was his world-first demonstration of the strong association between transcriptionally active high-risk HPV and both Barrett's dysplasia and oesophageal adenocarcinoma, with increasing viral load correlating with greater disease severity. His publication record includes 53 journal articles, 10 conference papers, and 1 book chapter, reflecting substantial contributions to understanding HPV's role in esophageal cancer development. The research has important implications for potential vaccination strategies against a subset of esophageal cancers. Professor Rajendra maintains active clinical and research connections through his work at NSW Health, with his findings contributing to both basic science understanding and potential clinical applications in cancer prevention and early detection.

• HIV Medicine
• Hepatitis C Treatment
• Family Medicine
• +3 more

Gregory H. Taylor, MD is a Professor in the Department of Family & Community Medicine at the University of Maryland School of Medicine with a secondary appointment in Medicine. He serves as Associate Director of the Evelyn Jordan Center and maintains clinical practice at 22 S. Greene St., Suite 300, Baltimore, specializing in HIV and Hepatitis C care for over two decades. His academic foundation includes: B.S. in Biology from Virginia Tech M.D. from University of Maryland School of Medicine Residency in Family Medicine at University of Maryland Dr. Taylor's research centers on HIV comorbidities, particularly tobacco-related pulmonary pathology in women, HPV-associated diseases, and Hepatitis C integration into primary care. His work bridges laboratory investigations, epidemiological studies, and clinical interventions to address health disparities in urban HIV populations. As an educator certified by the American Academy of HIV Medicine, he trains medical students through community physicians. Analysis of his 13 publications (2000-2016) reveals evolving focus from virology fundamentals to community-based implementation science. Early work examined opportunistic infections (CMV, Parvovirus) while recent studies address lung cancer screening in HIV smokers and anal cancer prevention, demonstrating progression toward population health solutions. His scientific recognition includes: Faculty Award for Outstanding Service (1994, 1997, 1999) Alpha Omega Alpha election (2000) Chairman's Community-Based Teaching Award (2001-2002) Community Preceptor Award (2003, 2010) Dr. Taylor has served as PI/co-PI on multiple NIH-funded studies and currently leads the Maryland Community-based Programs to Test and Cure Hepatitis C (Maryland DHMH grant). Through the Evelyn Jordan Center, he collaborates with multidisciplinary teams serving vulnerable populations affected by HIV and substance use disorders.

Jiayao LeiView profile

Assistant Professor

• Cancer Epidemiology
• Vaccine Epidemiology
• HPV Infection
• +7 more

Jiayao Lei is an Assistant Professor at Karolinska Institutet and a Visiting Senior Lecturer at Queen Mary University of London. Her work focuses on cancer epidemiology, particularly cervical cancer prevention through HPV vaccination and screening optimization. She is affiliated with the Department of Medical Epidemiology and Biostatistics, Department of Clinical Science, Intervention and Technology, and the Center for Cervical Cancer Elimination Modelling and simulation research group at KI. PhD in Medical Epidemiology and Biostatistics, Karolinska Institutet (2020) Master of Medical Science, Karolinska Institutet (2015) Her research spans cancer epidemiology, vaccine effectiveness, risk prediction modeling, and health economics. She leverages Swedish national registers and biobank data to evaluate HPV vaccination programs and cervical screening performance, contributing to WHO's cervical cancer elimination strategy. Her recent publications demonstrate a focus on HPV epidemiology, cervical cancer prevention, and infectious disease modeling. Key trends include population-based cohort studies, self-sampling methods, and cross-country SARS-CoV-2 transmission analyses. Scientific awards include the Dimitris N. Chorafas Prize 2020 for her thesis on cervical cancer prevention. Her work is funded by the Swedish Research Council, Forte, Swedish Cancer Society, and KI Strategic Research Area grants. As an educator, she teaches Clinical Cancer Epidemiology (KCL & KI) and Introduction to Epidemiology (Scandinavian Kiropractorhöskolan). Current team members include PhD student Eva Meglic, postdoc Yunyang Deng, and research assistants, with former advisees like Ana Martina Astorga Alsina.

Gabriella Lillsunde-LarssonView profile

Senior Lecturer

• Biomedicine
• Virology
• Oncology
• +5 more

Gabriella Lillsunde-Larsson is a Senior Lecturer and Associate Professor at the Örebro University School of Health Sciences , with a 30% appointment at the Department of Laboratory Medicine, Örebro University Hospital. Her work bridges biomedical laboratory science and clinical oncology , focusing on HPV-induced cancers and translational research. PhD in Biomedicine (2015) - Thesis: Characterization of HPV-induced vaginal and vulvar carcinoma Current research projects: HPV gene variation and protein expression as prognostic markers Molecular triage for cervical screening Prognostic biomarkers in prostate cancer Research Focus: Gabriella investigates biological and prognostic factors in HPV-induced genital cancers, prostate cancer, and endocannabinoid signaling. Her work includes cost-effectiveness analysis of self-sampling methods and international collaborations on cervical screening policies. Publications: Recent work explores molecular triage in cervical screening, HPV genotyping in HIV-endemic regions, and protein expression markers in vaginal carcinoma. Her studies (2022-2025) emphasize translational applications of HPV research and laboratory science innovations. Academic Leadership: Program Manager for the Master's Program in Methods in Medical Diagnostics Vice Chair of the Institute of Biomedical Laboratory Science (IBL) President of the International Federation of Biomedical Laboratory Science (IFBLS) since 2024 Örebro University representative in the Regional Cancer Center (RCC) Central Sweden International Engagement: Active in WHO collaborations through IFBLS, scientific committee member for global HPV congresses, and contributor to professional education standards across Nordic countries.

Naomi LeeView profile

Associate Professor

• Indigenous health disparities
• Biomedical research
• Vaccinology
• +4 more

Dr. Naomi Lee is an Associate Professor at Northern Arizona University in the Department of Chemistry and Biochemistry . Her research spans vaccinology , biochemistry , and STEM education with a focus on reducing health disparities in Native American communities . She leads the Lee Lab Research Group , which develops novel peptide-based therapeutics for HPV vaccines, cardiovascular disease prevention, and opioid addiction mitigation through methamphetamine hapten vaccines. Her work integrates Indigenous perspectives in public health research, particularly addressing vaginal microbiome variations contributing to cervical cancer disparities. She pioneers culturally relevant education programs to increase access for historically excluded students in STEM, evidenced by her Chemistry and Culture Workbook and collaborations with the Partnership for Native American Cancer Prevention . The 15 most recent publications demonstrate expertise in vaccinology , microbiome research , and health equity frameworks . Key subfields include virus-like particle engineering , opioid immunotherapy , Indigenous workforce development , and structural peptide optimization . Her team has received numerous scientific awards including the NIH NINDS Exceptional Summer Student Award , AISES Professional of the Year , and Barry Goldwater Scholarships for mentees. Student mentorship spans PhD candidates like Tawnjerae Joe at the University of Arizona, postdoctoral fellows such as Krystal Charley, and undergraduate researchers including Amaya Pablo working on silver nanocluster conjugation and Caleb Rice developing methamphetamine vaccines. Former students have pursued advanced degrees at institutions like Stanford , Johns Hopkins , and Kansas University . Lead researcher in NIH-funded HPV vaccine development Co-investigator in Community Health Representative programs for clinical trial trust-building Director of 4CSCC (Four Corners Science and Computing Club)

Karin SundströmView profile

Researcher

• Cancer Epidemiology
• Human Papillomavirus (HPV)
• Cervical Cancer Screening
• +6 more

Karin Sundström is a Principal Researcher at the Karolinska Institute , affiliated with the Department of Clinical Science, Intervention and Technology and leading the Human papillomavirus which causes cervical cancer – Research Group . She serves as a research group leader and cancer epidemiologist with extensive experience in molecular epidemiology and biobank infrastructure utilization. MD-PhD trained medical scientist Active in eHealth and big data applications Principal investigator for multiple international collaborations Research Interests: HPV-associated cancer elimination Biomarker development for female cancers Register-based cervical screening optimization Next-generation sequencing applications Machine learning in medical records analysis Epidemiology of herpes zoster Scientific Contributions: With over 20 publications in 2023-2024 alone, her work spans HPV vaccination effectiveness, cervical screening algorithms, and cancer risk stratification using epigenetic markers. Her MERMAID III initiative focuses on ovarian cancer prevention through biomarker research. Selected Awards: Swedish Cancer Society Project Grant (2022-2023) CIMED Junior Grant (2020-2022) Jonas Söderquist Award for Virology Research (2016) Academic Leadership: Supervises multiple doctoral and postdoctoral researchers including Dr. Jiangrong Wang, and serves as study director for KI's Diagnostic Cytology program. Previously coordinated the Nordic Information for Action eScience Center (NIASC) eHealth projects.

John RuizView profile

Professor

• Health Psychology
• Behavioral Medicine
• Social Epidemiology
• +5 more

John Ruiz serves as Professor in the Department of Psychology within the College of Science at the University of Arizona, where he directs the Social Risk and Resilience Factors (SuRRF) Lab and holds key leadership roles including Assistant Director of Strategy and Workforce Engagement at the University of Arizona Cancer Center. His research program investigates how social experiences constitute both risk and resilience mechanisms for physical health, with particular emphasis on racial/ethnic and cultural differences in health outcomes. The SuRRF Lab employs diverse methodologies including community cohort studies, ecological momentary assessment, ambulatory physiological monitoring, and laboratory paradigms to examine stress effects on cardiovascular health, social integration as resilience factor, and the mechanisms underlying the Hispanic Health Paradox. Current foci include stress-cardiovascular risk relationships, social vigilance as a modifiable factor, and drivers of ethnic health disparities. Ruiz's scholarly impact is reflected through his editorship of Health Psychology (2023-2028) and leadership roles with the US Preventive Services Task Force (2022-2026), APA Council of Editors (2025-2026), and Behavioral Medicine Research Council. His publication record demonstrates consistent contributions to understanding social determinants of health, with recent work spanning preventive service guidelines, cardiovascular psychophysiology, border health research, and climate-health intersections. Editor-in-Chief of APA's Health Psychology (2023-2028) Chair of APA Council of Editors (2025-2026) Member of US Preventive Services Task Force (2022-2026) President of Behavioral Medicine Research Council Member of APA Presidential Task Force on Psychology and Health Equity As Clinical Director of the SuRRF Lab, Ruiz leads research examining how social phenomena influence health through cardiovascular responses, population health patterns, and sociocultural experiences in daily life. His team investigates conditions including lung cancer, long COVID-19, and health disparities through innovative methodological approaches spanning electronic medical records analysis to acute laboratory paradigms. Current projects include the North Texas Heart Study examining longitudinal effects of social vigilance on atherosclerosis.

Sarah PeitzmeierView profile

Assistant Professor

• Gender-based violence
• Sexual health epidemiology
• Transgender health
• +5 more

Sarah Peitzmeier is an Assistant Professor at the University of Michigan School of Nursing and Department of Health Behavior and Health Equity. As a mixed-methods social epidemiologist, her research focuses on gender-based violence and sexual health disparities in marginalized populations including LGBTQ communities and sex workers. PhD in Public Health, Johns Hopkins Bloomberg School (2017) MSPH in Public Health, Johns Hopkins Bloomberg School (2012) BS/BA in Biology and Psychology, University of Maryland (2010) Her NIH-funded work addresses intimate partner violence (IPV) in transgender populations through tool development for healthcare screening, and she's pioneering campus-based interventions to reduce sexual assault against cisgender women and transgender undergraduates. She leads community-engaged research on chest binding health impacts and violence-related drivers of HIV/HPV transmission. Recent publications demonstrate methodological diversity spanning: Transphobia-driven IPV measurement Transmasculine cervical cancer screening Gender-affirming body modification safety STI/HIV risk assessment tools Economic vulnerability interventions Pandemic-era violence dynamics Peitzmeier's research bridges clinical epidemiology and policy analysis, with particular emphasis on trans-specific health interventions and trauma-informed service delivery systems. Contact: Email: speitzme@umich.edu Phone: 734-764-4176 Address: University of Michigan School of Nursing, 400 North Ingalls Building

• HIV/AIDS
• Cancer
• Implementation Science
• +5 more

Raul U. Hernandez-Ramirez is a Research Scientist in Biostatistics at the Center for Methods in Implementation and Prevention Science (CMIPS) at the Yale School of Public Health. He serves as Director of the Dissemination and Implementation Science Methods (DISM) Core at the Center for Interdisciplinary Research on AIDS (CIRA) and is an Affiliated Faculty member at the Yale Institute for Global Health. His work bridges biostatistics, implementation science, and global health research with a focus on practical applications for public health improvement. Dr. Hernandez-Ramirez earned his PhD in Public Health (Chronic Disease Epidemiology) from Yale University in 2018, following an MPhil in the same field in 2016. During his doctoral studies, he conducted research as a predoctoral visiting fellow at the National Cancer Institute (NCI). He further enhanced his expertise through specialized training programs including the Training Institute for Dissemination and Implementation Research in Cancer (TIDIRC) and the Multilevel Intervention Training Institute (MLTI) from NCI, as well as training in optimization of multicomponent interventions using the Multiphase Optimization Strategy (MOST). His research primarily focuses on HIV/AIDS, cancer, and implementation science. He develops and applies causal inference methods for evaluating HIV prevention interventions and methods to account for exposure uncertainty in environmental health studies. His work spans multiple settings including New Haven, other locations in the United States, and low- and middle-income countries, particularly Mexico. He is particularly interested in adapting and developing interventions to increase the uptake of evidence-based practices for HIV and cancer prevention and care, including follow-up care for abnormal cervical cancer screens. He is a member of the Yale Cancer Center (YCC) and the Yale Institute for Global Health (YIGH). Analysis of Dr. Hernandez-Ramirez's recent publications reveals a strong focus on gastric cancer epidemiology through the Stomach cancer Pooling (StoP) Project, examining dietary factors and their relationship to cancer risk. His work prominently features implementation science methodologies applied to HIV prevention and cancer screening programs, particularly in Mexican and other international settings. His research combines rigorous biostatistical methods with practical applications in global health contexts, with significant contributions to causal inference methods and network-randomized trial analysis. Provides expertise, consultations, and technical assistance on implementation science through CIRA's DISM core Contributes to projects in Ending the HIV Epidemic (EHE) priority areas through the CIRA-affiliated IS hub R3EDI Collaborates on research projects in New Haven, other US settings, and low- and middle-income countries including Mexico Offers seminars and trainings on research methods, design, and analysis to CIRA affiliates Dr. Hernandez-Ramirez previously gained substantial research experience in nutrition, environmental health, and cancer at the National Institute of Public Health of Mexico, where he worked as a researcher and instructor and served as project coordinator, data manager, and main statistician for a multistate study. He holds an MSc in Epidemiology and a BSc in Nutrition, establishing a strong foundation for his current work at the intersection of nutritional epidemiology and implementation science.

Caroline MitchellView profile

Associate Professor

• vaginal microbiome
• bacterial vaginosis
• women's reproductive health
• +5 more

Caroline Mitchell, MD, MPH is an Associate Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a faculty member in the Vincent Center for Reproductive Biology at Massachusetts General Hospital. She serves as the Director of the Vulvovaginal Disorders Program at MGH, where she sees patients with complex vulvovaginal disorders and recurrent vaginal infections. Dr. Mitchell's research focuses on the vaginal microbiome's role in women's reproductive health. Dr. Mitchell earned her undergraduate degree from Harvard College with a concentration in Women's Studies, followed by two years in the Peace Corps in Southern Africa as a high school science teacher. She completed medical school at Harvard Medical School and her OB/GYN residency training along with an MPH at the University of Washington in Seattle. After seven years on faculty at the University of Washington, she returned to Boston and Massachusetts General Hospital in 2014. Dr. Mitchell's research centers on understanding how vaginal microbes influence reproductive health and disease. Her lab conducts clinical studies, translational analyses, and bench experiments to identify key pathways in host-microbe interactions. The lab's work includes multiple ongoing clinical trials such as MOTIF (Modifying Organisms Transvaginally in Females), VIBRANT, THRIVE, and RituxiVag, focusing on vaginal microbiome transplants, HPV persistence, and the relationship between vaginal immunity and microbiome. Analysis of Dr. Mitchell's recent publications reveals a strong focus on the vaginal microbiome's role in women's health across different life stages. Her work spans basic science investigations of host-microbe interactions, clinical trials of microbiome-based therapies, and epidemiological studies of vaginal health conditions. Key themes include bacterial vaginosis, menopausal vaginal health, HPV persistence, and the development of novel microbiome-based interventions. Dr. Mitchell has received significant research funding from prestigious organizations including the NIH, Doris Duke Foundation, Bill & Melinda Gates Foundation, American Association of Obstetricians & Gynecologists Fund, and the MGH Claflin Award. She is an active member of the Vaginal Microbiome Research Consortium. Dr. Mitchell leads the Mitchell Lab, which includes several researchers working on various aspects of vaginal microbiome research. Her lab maintains close collaborations with the Kwon Lab at the Ragon Institute and participates in the MsFlash menopause research network. The lab's work bridges basic science, clinical research, and patient care to develop novel interventions for improving women's reproductive health.

Sihong WangView profile

Associate Professor

• Biomedical Engineering
• Microfluidics
• Tissue Engineering
• +3 more

Sihong Wang serves as an Associate Professor within the Department of Biomedical Engineering at the City College of New York (CCNY), part of the City University of New York system. His research laboratory is housed in Steinman Hall (Room 434), where he develops advanced microfluidic platforms for biomedical applications. Dr. Wang maintains active research collaborations across engineering and life science disciplines, with contact facilitated through shwang@ccny.cuny.edu and phone 212-650-5189. Dr. Wang's research program centers on innovative microfluidic technologies that model complex biological systems with clinical relevance. His work bridges engineering precision with biological inquiry to create dynamic in vitro platforms for tumor microenvironment simulation, immune cell interaction studies, and stem cell differentiation analysis. Key focus areas include thermal modulation of cellular responses, high-throughput drug screening systems, and CRISPR-based validation of therapeutic mechanisms. This research directly impacts cancer immunotherapy development, regenerative medicine strategies, and pharmacological testing paradigms through engineered microenvironments that recapitulate physiological conditions. Analysis of Dr. Wang's publication trajectory (2013-2024) reveals an escalating sophistication in microfluidic platform design, evolving from foundational heat shock protein kinetics studies toward integrated systems for immune cell recirculation and tumor-stroma interaction modeling. His recent work demonstrates consistent innovation in creating dynamic, physiologically relevant microenvironments that capture temporal cellular responses—particularly evident in 2022-2024 immunotherapy-focused publications. The research consistently applies engineering principles to solve biological challenges, with increasing emphasis on clinical translation of microfluidic technologies for cancer treatment assessment. No scientific awards, graduate student mentorship records, research grant details, or laboratory infrastructure descriptions were documented in the source materials. Similarly, information regarding collaborative teams, future research directions, or educational background remains undisclosed in the available information.

Megan SwansonView profile

Assistant Professor

• Cervical Cancer
• Global Health Disparities
• Cancer Screening and Prevention
• +3 more

Megan Swanson, MD, MPH is an Assistant Professor in the Department of Ob/Gyn & Reproductive Sciences at the University of California San Francisco (UCSF), specializing in gynecologic oncology. She focuses on cervical cancer disparities, particularly in low-resource settings, and has conducted extensive research in East Africa. Dr. Swanson’s work includes developing cervical cancer screening programs in Uganda and addressing barriers to care in resource-limited regions. Education: Stanford University (BA Human Biology, 2004), UC Berkeley (MPH Maternal Child Health, 2010), UCSF School of Medicine (MD, 2011), UCSF Ob/Gyn Residency (2015), and UCSF Gynecologic Oncology Fellowship (2019). Research Interests: Global health disparities in cervical cancer outcomes, implementation of effective screening methods in low-income countries, and healthcare access innovations. She has collaborated with Makerere University and the Uganda Cancer Institute to improve cervical cancer care infrastructure. Publications: Her articles focus on cervical cancer screening strategies, HPV detection in community settings, and adapting clinical guidelines for resource-limited environments. Notable work includes studies in Uganda and Kenya published in *Infectious Agents and Cancer*, *BMC Women's Health*, and *Gynecologic Oncology Reports*. Awards: Recipient of the NIH Fogerty International Center GloCal Health Fellowship (2016), multiple teaching awards, and recognition for family planning excellence during residency. Labs/Teams: Collaborates with global health initiatives at UCSF and international partners in Uganda to advance cervical cancer prevention and treatment access.

Rebecca Richards-KortumView profile

Professor

• Biomedical Engineering
• Global Health Technologies
• Optical Imaging
• +5 more

Rebecca Richards-Kortum is the Malcolm Gillis University Professor and Professor of Bioengineering at Rice University, and Co-Director of the Rice360 Institute for Global Health Technologies. Her research focuses on developing low-cost, high-performance medical technologies for low-resource settings, addressing diseases like cervical cancer, neonatal mortality, and malaria. She leads the NEST360 initiative, a $68M global alliance targeting newborn mortality reduction in sub-Saharan Africa. Education: Ph.D. in Medical Physics (MIT, 1990), M.S. Physics (MIT, 1987), B.S. Physics and Mathematics (University of Nebraska-Lincoln, 1985) Affiliations: Collaboration with UT MD Anderson Cancer Center, Baylor College of Medicine, and institutions in Malawi, Brazil, and beyond. Her research integrates optical imaging, nanotechnology, and microfabrication to create tools like high-resolution microendoscopes for early cancer detection. She holds 40 patents and has authored over 315 papers. Awards include the MacArthur 'Genius' Grant (2016), membership in the National Academies of Sciences and Engineering, and the George R. Brown Award for Teaching (2014, 2016). Her labs, including the Optical Spectroscopy & Imaging Lab, emphasize global health equity. Recent work includes a $15M MacArthur grant for NEST360, which deploys 17 neonatal technologies to prevent 85% of African newborn deaths. She also co-founded the Beyond Traditional Borders (BTB) program, an engineering education initiative recognized by Science magazine.

Rachel MahasView profile

Assistant Professor

• Cancer disparities
• health behavior research
• community outreach and engagement strategies
• +4 more

Rachel Mahas serves as Assistant Professor and MPH Program Director in the Department of Family Medicine and Public Health Sciences at Wayne State University School of Medicine. Her work integrates public health research with medical education, focusing on community-based cancer prevention initiatives across the cancer continuum. Her educational background includes: Ph.D. in Health Education (University of Toledo, School of Population Health) with Epidemiology cognate M.S. in Basic Medical Sciences (Wayne State University School of Medicine) M.P.H. and B.S. in Clinical Laboratory Sciences (Georgia Southern University, with Honors) Dr. Mahas specializes in cancer disparities research, employing survey methodology to examine health behaviors from screening through survivorship. Her work investigates community engagement strategies, HPV vaccination uptake, and multivitamin use patterns using national datasets like the Health Information National Trends Survey. She emphasizes translating research into public health practice through curriculum development. Her publication history reveals consistent focus on women's cancer prevention, with recent work analyzing international cervical cancer policies and racial disparities in screening adherence. Key themes include health information seeking behaviors, psychosocial determinants of care, and methodological innovations in population health surveys. Professional recognition includes: Over 10 Quality Matters certificates for online course design WSU Online Course Quality Fellowship from the Office of the Provost Site visitor role for the Council on Education for Public Health As MPH Program Director, she develops health education curricula and teaches core public health courses including Foundations of Public Health and Public Health Policy, demonstrating commitment to training future public health professionals.

• Pediatric primary care
• School health
• Vaccine delivery and hesitancy
• +3 more

Mandy Allison, MD, is Professor of Pediatrics-General Pediatrics at the University of Colorado Anschutz Medical Campus School of Medicine. She practices at Children’s Hospital Colorado, is board-certified in Pediatrics, and is a Fellow of the American Academy of Pediatrics where she serves on the Council on School Health Executive Committee. Education & Training BA, Williams College (1995) MEd, University of Mississippi (1997) MD, University of Utah School of Medicine (2001) Residency, Pediatrics, University of Utah (2004) MSPH, University of Colorado Health Sciences Center (2006) Fellowship, Pediatrics, University of Colorado / Children’s Hospital Colorado (2006) Research Focus Dr. Allison’s scholarship centers on improving child health through evidence-based interventions in primary care and community settings. Her work integrates health-services research, implementation science, and policy analysis to advance vaccine delivery, school-based health programs, and early childhood development initiatives. She employs qualitative, quantitative, and mixed-methods approaches to evaluate complex interventions such as nurse-family partnerships, mobile-health tools for early language development, and cross-sector collaboration among home-visiting nurses, physicians, and community agencies. Publication Themes Across 89 peer-reviewed publications (2012–2024), her research clusters into four major themes: (1) optimizing vaccine uptake and financing in pediatric and adult primary care; (2) evaluating large-scale home-visiting programs with emphasis on maternal–child outcomes and health-equity; (3) developing and testing digital health and mobile interventions to support early cognitive and language development for low-income families; and (4) examining school-centered health services, chronic absenteeism, and the pediatrician’s role in school readiness. Scientific Awards Excellence in Teaching Award, University of Utah Triple Board Residents (2012) Excellence in Teaching Award, University of Utah Pediatrics Residents (2008) Grants, Advising & Collaborations While specific grant numbers are not detailed, Dr. Allison collaborates extensively through ACCORDS (Adult & Child Center for Outcomes Research & Delivery Science) and the Prevention Research Center for Family & Child Health. She mentors trainees across pediatrics, public health, and health-services research, contributes to interdisciplinary grant proposals, and leads pilot projects in implementation science and community-engaged research. Professional Memberships & Centers American Academy of Pediatrics (Fellow; Council on School Health Executive Committee) American School Health Association Society for Pediatric Research Academic Pediatric Association ACCORDS (Adult & Child Center for Outcomes Research & Delivery Science) Prevention Research Center for Family & Child Health